Clinical Trial Update: Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3) [Phase 3]

View source ↗

Summary

Phase 3 CHANCE-3 trial evaluating colchicine in high-risk patients after acute minor-to-moderate ischemic stroke or transient ischemic attack has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, TIA | Phase 3 | Status: COMPLETED